Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Unmet Needs of Patients Feeling Severely Affected by Multiple Sclerosis in Germany: A Qualitative Study.
Vital role of specialist MS nurses recognised in proposed guideline.
Audiological evidence of therapeutic effect of steroid treatment in neuromyelitis optica with hearing loss.
Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status.
Vitamin D immunomodulatory potential in multiple sclerosis.
Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis.
Multiple sclerosis: Lessons from molecular neuropathology.
Cost effectiveness of a pragmatic exercise intervention (EXIMS) for people with multiple sclerosis: economic evaluation of a randomised controlled trial.
Recent achievements in stem cell-mediated myelin repair.
Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis.
Multiple sclerosis: Neuroimaging provides insights into cognitive dysfunction in MS.
Patient-identified factors that influence spasticity in people with stroke and multiple sclerosis receiving botulinum toxin injection treatments.
Neuro-Ophthalmic Syndromes and Processing Speed in Multiple Sclerosis.
The effect of group psycho-education program on the burden of family caregivers with multiple sclerosis patients in Isfahan in 2013-2014.
Optical Coherence Tomography for the Detection of Remote Optic Neuritis in Multiple Sclerosis.
A basic overview of multiple sclerosis immunopathology.
M. paratuberculosis Heat Shock Protein 65 and Human Diseases: Bridging Infection and Autoimmunity.
Neuromyelitis optica antibody in Leber hereditary optic neuropathy: case report.
Reduced fingolimod dosage treatment for patients with multiple sclerosis and lymphopenia or neutropenia.
Tadeusz Markiewicz - the researcher's profile and his role in the studies on neuromyelitis optica.
24S-hydroxycholesterol in plasma: A marker of cholesterol turnover in neurodegenerative diseases.
The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells.
Impact of Sativex(®) on quality of life and activities of daily living in patients with multiple sclerosis spasticity.
Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica.
Genetic associations with brain cortical thickness in multiple sclerosis.

Pages